Overview

Efficacy and Safety Study of Octafibrin for On-demand Treatment of Acute Bleeding and to Prevent Bleeding During and After Surgery

Status:
Completed
Trial end date:
2018-02-14
Target enrollment:
Participant gender:
Summary
The purpose of the study is to assess the efficacy and safety of Octafibrin for on-demand treatment of acute bleeding in subjects with congenital fibrinogen deficiency.
Phase:
Phase 3
Details
Lead Sponsor:
Octapharma